Tapering the taper talk



May 7 (Reuters) - A look at the day ahead from Thyagaraju Adinarayan.

A million or more jobs added in April won't be enough to trigger the Fed to ponder its bond purchases is what Atlanta Fed's President Raphael Bostic said on Thursday, but markets appear to be wanting to front run any potential tapering with the S&P 500 .SPX stopping just shy of record highs.

The non-farm payrolls report due later today is likely to set the tone for markets - especially U.S. Treasuries, which traded in a tight range this week. Estimates for jobs created in April range widely between 700,000 and more than 2 million.

The reflation trade has been the only game in town as vaccinations gather pace and that's also supporting the red-hot rally in commodities that shows no signs of abating with oil, iron ore and copper all rising sharply. And those markets will be underpinned by China extending its impressive trade performance in April with exports jumping a third and import growth at a decade high.

In more good news, earnings season is continuing to surprise on the upside in Europe and the United States. German sportswear company Adidas ADSGn.DE said it expects strong demand for its products despite supply chain issues and lockdowns in Europe. Similarly, Siemens SIEGn.DE raised its outlook even as it flagged tightening supply chains.

Those strong earnings prints are set help Europe's benchmark STOXX 600 .STOXX index to open at record highs. U.S. stock futures are also ticking higher.

Elsewhere, the world's second-largest cryptocurrency Ether ETH=BTSP hit yet another record high, taking year-to-date gains to over 385%, as investors diverted focus from its main rival bitcoin BTC=BTSP .

Key developments that should provide more direction to markets on Friday:

- Credit Agricole posts 64% jump in profits

- BMW confirms outlook, but says rest of 2021 to be volatile

- British Airways cautious on short term flying recovery

- ECB President Christine Lagarde speaks at 1000 GMT

- US non-farm payrolls data 1230 GMT

- US earnings: Cigna, Fluor



Cryptos explode to new highs Link



Reporting by Thyagaraju Adinarayan, editing by Karin
Strohecker

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.